From this, we hypothesize that the active substance β-elemene regulates the expression of the potential molecular markers VDR and VEGFC by acting on PTGS1 and PTGS2 to affect anoikis in NSCLC cells. This evidence concerns the gene VEGFC and non-small cell lung carcinoma.